Results 221 to 230 of about 577,742 (361)

Prognostic implications of cytogenetic studies in an intensively treated group of children with acute lymphoblastic leukemia [PDF]

open access: bronze, 1989
JA Fletcher   +7 more
openalex   +1 more source

Synergistic Efficacy of Chidamide and LB100 in Sézary Syndrome via TNC Downregulation and PI3K/AKT/mTOR Dephosphorylation

open access: yesCancer Science, EarlyView.
Chidamide combined with LB100 can effectively promote the death of Sézary Syndrome by inhibiting the expression of TNC and the phosphorylation of PI3K/AKT/mTOR. ABSTRACT Primary cutaneous T‐cell lymphoma (CTCL) manifests as a distinct variant of T‐cell non‐Hodgkin's lymphoma, predominantly impacting skin tissues and constituting approximately 75%–80 ...
Nan Chen   +7 more
wiley   +1 more source

Oncologists' preferences for frontline TKI treatment of Ph+ acute lymphoblastic leukemia: a discrete choice experiment. [PDF]

open access: yesFuture Oncol
Ashaye A   +8 more
europepmc   +1 more source

Marrow transplantation for patients with acute lymphoblastic leukemia: a long-term follow-up

open access: bronze, 1983
Thomas Ed   +9 more
openalex   +1 more source

Canonical and Non‐Canonical Functions of Histone H3K4 Methylation Modifiers in Cancer

open access: yesCancer Science, EarlyView.
Histone H3K4‐modifying enzymes regulate gene expression and cellular processes critical to cancer development. Beyond their canonical roles, these enzymes also exhibit non‐catalytic and non‐histone functions, offering new opportunities for therapeutic intervention. ABSTRACT Histone H3K4 modifications are altered in the regulation of gene expression and
Takayuki Hoshii
wiley   +1 more source

Ataxia-telangiectasia and acute lymphoblastic leukemia

open access: bronze, 1980
Stuart R. Toledano, Beverly J. Lange
openalex   +1 more source

Translocation t(1;19)(q21;q13) in acute lymphoblastic leukemia [PDF]

open access: bronze, 1984
Christiane Werner‐Favre   +3 more
openalex   +1 more source

Comparative Analysis of a Dual DNA–RNA Panel and a DNA‐Only Panel for Sarcoma: Real‐World Data From a Nationwide Genomic Database

open access: yesCancer Science, EarlyView.
Dual DNA–RNA panel with matched tumor–normal testing may improve diagnostic accuracy and inform treatment decisions in the routine clinical management of sarcoma. ABSTRACT Next‐generation sequencing‐based comprehensive cancer genomic profiling is promising in cancer management; however, most studies rely on tumor‐only DNA panels from single ...
Eiji Nakata   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy